The novel treatment of the medication represents a significant development in the management of diabetes mellitus type 2. Unlike existing medications, tirzepatide impacts dual pathways – GLP-1 and the GIP hormone – https://tirzepatidepeptide399405.gynoblog.com/40714322/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment